Keywords: phase, iii, trial, loteprednol, pharmos, corporation, israel

PHASE III TRIAL OF LOTEPREDNOL

Article | 07 March 1994

Pharmos Corporation of Israel has announced that it has successfully completed the first of four pivotal Phase III trials of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in